The United Kingdom caps exenatide prescribing to 20 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Pricing
Page 24 of 25 of this archive, newest first.
From the floor in Zhuhai: 18 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Norway declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
France declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
From the floor in Changsha: 12 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The United Arab Emirates caps tirzepatide prescribing to 11 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Saudi Arabia declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Saudi Arabia caps exenatide prescribing to 11 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Denmark caps exenatide prescribing to 22 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Seasonal use, holiday use, and the honest state of the evidence
A great deal of practice has grown up around intermittent schedules. The randomised evidence for any of them is, as far as the Journal can establish, nil.
Portugal declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Argentina caps exenatide prescribing to 22 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The United Kingdom declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
South Korea caps dulaglutide prescribing to 4 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
From the floor in Hangzhou: 11 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The dose that got you here and the dose that keeps you here
The commonest real-world strategy in this drug class is the least studied one.